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Breast Cancer Awareness and Barriers  
to Early Presentation in the Gaza-Strip:  
A Cross-Sectional Study
INTRODUCTION
Breast cancer (BC) is the most commonly diag-
nosed cancer among women worldwide.1 In 
Gaza, BC accounts for 31.3% of all reported 
cancer occurrences among Palestinian women: 
its prevalence is 149.1 per 100.000. In Pales-
tine, BC is the leading cause of cancer-related 
deaths among women: its mortality rate is 9.8%.2
This could be attributed to the diagnosis at 
advanced stages because of low awareness lev-
els of BC symptoms or risk factors and difficult 
access to health care. Hence, the importance 
of knowledge about BC signs and symptoms 
as well as risk factors (eg, age, family history, 
early menarche, and hormone replacement 
therapy3,4) and the need for every woman to be 
aware of and engaged with a BC screening can-
not be under-emphasized.
Additional reasons for the relatively high preva-
lence of BC in Palestine include the presence 
of social stigma, fear, and reduced engagement 
in screening behaviors, such as breast self- 
examination (BSE).5 BSE is one of the three 
screening tests considered for early detection of 
BC: clinical breast examination, x-ray mammog-
raphy, and BSE.6 In 2003, the American Cancer 
Society recommended education about BSE for 
women age 20 years and older, but women should 
know that BSE is most suitable for interval 
screening.7 It is important to realize that the con-
cepts of breast awareness and BC awareness 
are inextricably linked, because women must be 
confident to look at and feel their breasts so that 
they can know what is normal for their own body 
and what changes to notice and then report to 
their health care providers.8-10
Purpose Timely detection of breast cancer (BC) is important to reduce its related deaths. Hence, 
high awareness of its symptoms and risk factors is required. This study aimed to assess the aware-
ness level of BC among females in Gaza. 
Materials and Methods A cross-sectional study was performed during September and October 
2017 in Gaza, Palestine. Stratified sampling was used to recruit patients from four hospitals and 
seven high schools. The validated Breast Cancer Awareness Measure (BCAM) was used to as-
sess confidence and behavior in relation to breast changes, awareness of BC symptoms and risk 
factors, barriers to seek medical help, and knowledge of BC screening. Women (age ≥ 18 years) 
visiting or admitted to any of the four hospitals, and female adolescents (age 15 to 17 years) in 
any of the seven schools, were recruited for face-to-face interviews to complete the BCAM. 
Results Of 3,055 women approached, 2,774 participants completed the BCAM questionnaire (re-
sponse rate, 90.8%); 1,588 (57.2%) were adults, and 1,186 (42.8%) were adolescents. Of these, 
1,781 (64.2%) rarely (or never) checked their breasts, and 909 (32.8%) were not confident to 
notice changes. In total, 1,675 (60.4%) were aware of the availability of BC screening programs. 
The overall mean ± standard deviation score for awareness of BC symptoms was 5.9 ± 2.9 of 11, 
and that of risk factors 7.5 ± 3.1 of 16. Feeling scared was the most reported barrier to seeking 
advice reported among women (n = 802; 50.2%), whereas feeling embarrassed was the most 
reported in adolescents (n = 745; 62.8%). 
Conclusion Awareness of BC symptoms, risk factors, and screening programs is suboptimal in 
Gaza. Educational interventions are necessary to increase public awareness of BC and to train 
local female breast surgeons to address barriers to early detection.
 © 2018 by American Society of Clinical Oncology Licensed under the Creative Commons Attribution 4.0 License
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The poor knowledge and misleading beliefs 
about BC among women are responsible for a 
negative perception of the likelihood for a cure 
if detected early and the efficacy of screening 
tests.11 Studies that tackled the different aspects 
of BC awareness among Arab women were few 
and revealed a lack of BC knowledge among 
women.12-15 In Gaza, breast screening is avail-
able, but the program is not disseminated well, 
and no general awareness of such a program 
exists. Only women who get to know about the 
program and the location of screening from a 
health care professional usually can take part—
many women remain unaware of the available 
screening program.16,17
To our knowledge, this is the first study con-
ducted in the Gaza Strip to assess BC knowledge 
among women in Gaza, the attitude of these 
women toward BC, the awareness of BC age- 
related and lifetime risks and availability of a BC 
screening program, and to uncover the barriers 
to seeking medical help.
MATERIALS AND METHODS
Study Design and Population
A cross-sectional study was conducted from 
September 1 to October 31, 2017. It assessed 
BC awareness and attitudes toward BC among 
adolescent and adult women in the Gaza Strip. As 
an assessment tool, the Breast Cancer Awareness 
Measure (BCAM) questionnaire, which is a vali-
dated standardized measurement for BC aware-
ness in the general population, was used.18 The 
questionnaire consists of three sections; the first 
evaluated behaviors in relation to breast changes 
as well as knowledge of age-related and lifetime 
BC risk in addition to the availability of a BC 
screening program in Gaza. The second sec-
tion posed open-ended (recall) questions, and 
the third included closed (recognition) ques-
tions with a comparison between both outcomes 
(recall v recognition).
A 3-point Likert scale was used to evaluate 
knowledge of BC symptoms and signs as well 
as to explore barriers to seeking medical help, 
which were categorized into emotional, practical, 
and service barriers. A 5-point Likert scale was 
used to assess the awareness of BC risk factors.
The BCAM was translated from English to Arabic 
and then back-translated into English by several 
people proficient in both languages. A pilot study 
was conducted with 78 respondents to test the 
clarity of the questions of the Arabic BCAM ver-
sion. A reliability analysis was carried out on the 
resulting task value scale composed of 29 items. 
Cronbach’s α showed that the questionnaire 
reached acceptable reliability (α = .757). Most 
items were worthy of retention; that is, deletion of 
the item resulted in a decrease in the α.
Sampling Methods
Governmental hospitals are the main entry point 
for health care services in Gaza. Therefore, adult 
women age 18 years or older who were admit-
ted to or visiting those hospitals were the target 
population and were recruited to participate. 
Patients or visitors to oncology departments were 
excluded from the study.
There are 13 hospitals in the Gaza Strip.2 From 
these, the largest four hospitals, located in 
four separate geographic locations in the Gaza 
Strip—namely, the North, including Gaza City; 
the Middle Governorate, Khan Younis, and the 
South—were chosen for recruitment of adult 
women and adolescent participants by stratified 
sampling. This sampling area covered most of 
the Gaza population and produced a representa-
tive sample from across the Gaza Strip. Parallel 
to this, adolescents from seven high schools (of 
75 female-only high schools in Gaza19) located 
in the same areas as the study hospitals were 
recruited to achieve uniformity of areas. Adoles-
cents age 15 to 17 years study health-related 
topics in their high-school curriculums, so there 
is an opportunity to explore their awareness 
of BC. Participants were invited to face-to-face 
interviews for completion of the BCAM.
Data collectors were trained to recruit partici-
pants, distribute questionnaires, and facilitate 
completion. They were also trained to admin-
ister the questionnaire to illiterate participants. 
Before completion of the questionnaire, a detailed 
explanation of the study, including its purposes, 
was given to the participants. Informed consent 
was obtained from the participants, and ethical 
approval was obtained from both the Palestin-
ian Ministry of Health and the Ministry of Higher 
Education.
Statistical Methods
Descriptive statistics were calculated for demo-
graphic data and behaviors in relation to breast 
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changes by the participants. Cumulative scores 
were then calculated for the recognition of BC 
signs and symptoms, risk factors, and reported 
barriers. When recognition questions of BC 
symptoms were used, the “I do not know” 
responses were considered ”No” responses; 
thus the 3-point Likert scale (ie, yes, no, I do 
not know) was converted into a 2-point scale 
(ie, yes or no) to facilitate comparison of differ-
ent responses to recognition versus recall ques-
tions.13
The 5-point Likert scale was also converted into 
a 3-point scale, because it was difficult for par-
ticipants to distinguish between the “agree” ver-
sus “strongly agree” and the “disagree” versus 
“strongly disagree” responses. The responses 
of “strongly agree” and “strongly disagree” were 
recoded to “agree” and “disagree,” respectively, 
using statistical software as described previ-
ously.13
The χ2 test was used to compare the aware-
ness of each BC symptom between adults and 
adolescents. The variable of interest was the 
mean score of overall awareness, for which the 
one-sample t test was used for each section and 
the two-sample t test was used to compare the 
mean scores of knowledge among adults and 
adolescents. Data were analyzed using the Sta-
tistical Package for the Social Sciences version 
22 (IBM Corporation, Chicago, IL).
RESULTS
Of the 3,055 invited participants, 2,774 com-
pleted the BCAM questionnaire (response rate, 
90.8%). Among them, 1,588 (57.2%) were adults 
and had a mean (standard deviation [SD]) age of 
34.1 ± 12.2 years; 1,186 (42.8%) were adoles-
cents and had a mean ± SD age of 16.2 ± 0.9 
years (Table 1).
A total of 1,781 (64.2%) reported that they 
rarely (or never) checked their breasts, and 909 
(32.8%) were not confident to notice changes 
(Table 2). Only 60 participants (2.2%) gave a 
correct answer for the age-related risk of BC, 
whereas 1,181 (42.6%) answered the question 
for lifetime risk correctly (Table 3).
A total of 1,675 participants (60.4%) knew about 
the availability of a BC screening program in 
Gaza. However, only 329 (23.8%) reported its 
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Table 1. Statistics of Age Groups Among Women Tested
Group No. (%) Mean (± SD) Age (years) Age Range (years)
Adolescent women 1,186 (42.8) 16.2 (± 0.9) 15.0-17.0
Adult women 1,588 (57.2) 34.1 (± 12.2) 18.0-92.0
Total 2,774 (100.0) 26.4 (± 12.8) 15.0-92.0
Abbreviation: SD, standard deviation.
Table 2. Summary of Frequency of Behaviors in Relation to Breast Changes in Women Tested
Behavior
Total 
(N = 2,774)
Adolescents 
(n = 1,186)
Adults 
(n = 1,588)
Breast self-examination
Rarely or never 1,781 (64.2) 1,043 (87.9) 738 (46.5)
At least once every 6 months 322 (11.6) 41 (3.5) 281 (17.7)
At least once a month 407 (14.7) 44 (3.7) 363 (22.9)
At least once a week 264 (9.5) 58 (4.9) 206 (12.9)
Confidence to notice a change in breasts
Not at all confident 909 (32.8) 574 (48.4) 335 (21.1)
Slightly confident 577 (20.8) 301 (25.4) 276 (17.4)
Fairly confident 513 (18.5) 164 (13.8) 349 (21.9)
Very confident 775 (27.9) 147 (12.4) 628 (39.6)
Doctor visit for a noticed change in a breast
Yes 402 (14.5) 47 (3.9) 355 (22.4)
No 1,241 (44.7) 590 (49.7) 651 (40.9)
Did not notice any change 1,131 (40.8) 549 (46.4) 582 (36.7)
NOTE. Data are No. (%).
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true starting age at 40 years. In general, aware-
ness of BC symptoms and warning signs as well 
as risk factors was low when open-ended (recall) 
questions were used and was higher with closed 
(recognition) questions. The overall mean ± SD 
score for recognition of BC symptoms was 5.9 ± 
2.9 of 11, and adults demonstrated higher 
awareness than adolescents (6.8 v 4.8 of 11; P = 
.08). Adults demonstrated a significantly higher 
recall and recognition of all signs and symptoms 
of BC than adolescents except in recall about 
change of nipple position and change of breast/
nipple shape (Table 4). A breast lump was 
the most commonly recognized symptom (n = 
2,166; 78.1%), whereas pulling in of nipple was 
the least recognized (n = 1,009; 36.4%).
The overall mean ± SD score for recognition of 
BC risk factors was 7.5 ± 3.1 of 16, and adults 
showed a significantly better knowledge than 
adolescents overall (8.0 v 6.8 of 16; P < .001) as 
well as in every BC risk factor (Table 5). A past 
history of BC was the most frequently reported 
BC risk factor (n = 1,333; 48.1%) and early 
menarche was the least (n = 430; 15.5%).
Overall, emotional barriers were the most com-
monly reported barriers to seeking medical help; 
feeling embarrassed was the first reason (n = 
1,536; 55.4%), and this was also the most fre-
quently reported barrier among adolescents (n = 
745; 62.8%). Conversely, feeling scared was the 
most frequently reported reason among adults 
(n = 802; 50.6%; Table 6).
DISCUSSION
The overall awareness of BC in this study was 
suboptimal. Adult women demonstrated higher 
awareness than adolescents, especially in obser-
vations about breast changes and knowledge 
about the age-related risk. A major difference 
was observed in the emotional barriers; feeling 
embarrassed was reported as the most com-
mon barrier to seeing a doctor by adolescents, 
and being scared was the most common barrier 
reported by adults.
To our knowledge, this is the first study to 
examine BC awareness in Gaza and Palestine, 
where—given the difficult economic circum-
stances and high prevalence of BC—effective 
prevention strategies and early recognition are 
essential to increase BC survival to international 
levels. Awareness of BC symptoms and risk fac-
tors as well as reduction of the barriers to seek-
ing medical advice are crucial to achieve this 
goal. This study looked at these factors to sup-
port the development of effective policies in the 
public health and education sectors.
BSE is one of the most cost effective and 
accessible interval screening methods available.7 
However, only 35.8% of participants reported 
BSE performance compared with 87.8% in a 
study from Bangladesh.16 Forbes et al20 found 
that 52.0% of women in East London were fairly 
or very confident in the ability to notice any 
breast change, and this rate was higher than 
the proportion found in this study—46.4%. In 
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Table 3. Summary of Knowledge of Age-Related and Lifetime Risk in Women Tested
Knowledge
Total 
(N = 2,774)
Adolescents 
(n = 1,186)
Adults 
(n = 1,588)
In the next year, who is most likely to get breast cancer?
A 30-year-old woman 649 (23.4) 300 (25.3) 349 (22.0)
A 50-year-old woman 455 (16.4) 117 (9.9) 338 (21.3)
A 70-year-old woman 60(2.2) 28 (2.4) 32 (2.0)
A woman of any age 1,556 (56.1) 698 (58.9) 858 (54.0)
I do not know 54 (1.9) 43 (3.6) 11 (0.7)
How many women will develop breast cancer in their 
lifetime?
1 in 3 women 592 (21.3) 280 (23.6) 312 (19.6)
1 in 9 women 1,181 (42.6) 497 (41.9) 684 (43.1)
1 in 100 women 695 (25.1) 247 (20.8) 448 (28.2)
1 in 1,000 women 194 (7.0) 84 (7.1) 110 (6.9)
I do not know 112 (4.0) 78 (6.6) 34 (2.1)
NOTE. Data are No. (%).
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Table 6. Summary of Barriers to Seeking Medical Advice in Women Tested
Barrier by Type
Total 
(N = 2,774)
Adolescents 
(n = 1,186)
Adults 
(n = 1,588) P
Emotional
Embarrassment
Yes 1,536 (55.4) 745 (62.8) 791 (49.8) < .001
No 1,131 (40.8) 360 (30.4) 771 (48.6)
Participant does not know 107 (3.8) 81 (6.8) 26 (1.6)
Feeling scared
Yes 1,449 (52.2) 647 (54.6) 802 (50.6) < .001
No 1,195 (43.1) 445 (37.5) 750 (47.2)
Participant does not know 129 (4.7) 94 (7.9) 35 (2.2)
Would not feel confident talking about symptom with 
doctor
Yes 983 (35.4) 531 (44.8) 452 (28.5) < .001
No 1,580 (57.0) 510 (43.0) 1,070 (67.4)
Participant does not know 211 (7.6) 145 (12.2) 66 (4.1)
Feeling worried about what a doctor might find
Yes 1,353 (48.8) 605 (51.0) 748 (47.1) < .001
No 1,214 (43.8) 439 (37.0) 775 (48.8)
Participant does not know 207 (7.4) 142 (12.0) 65 (4.1)
Service
Feeling worried about wasting doctor’s time
Yes 398 (14.4) 187 (15.8) 211 (13.3) < .001
No 2,170 (78.2) 861 (72.6) 1,309 (82.4)
Participant does not know 206 (7.4) 138 (11.6) 68 (4.3)
Difficulty talking to doctor
Yes 421 (15.2) 156 (13.2) 265 (16.7) < .001
No 2,097 (75.6) 866 (73.0) 1,231 (77.5)
Participant does not know 256 (9.2) 164 (13.8) 92 (5.8)
Difficulty making an appointment with the doctor
Yes 658 (23.7) 287 (24.2) 371 (23.4) < .001
No 1,884 (67.9) 737 (62.1) 1,147 (72.2)
Participant does not know 232 (8.4) 162 (13.7) 70 (4.4)
Practical
Too busy to go to the doctor
Yes 806 (29.1) 360 (30.4) 446 (28.1) < .001
No 1,775 (63.9) 699 (58.9) 1,076 (67.8)
Participant does not know 193 (7.0) 127 (10.7) 66 (4.1)
Has other things to do
Yes 662 (23.9) 278 (23.4) 384 (24.2) < .001
No 1,904 (68.6) 767 (64.7) 1,137 (71.6)
Participant does not know 208 (7.5) 141 (11.9) 67 (4.2)
Difficulty arranging transports to the doctor
Yes 778 (28.1) 254 (21.4) 524 (33.0) < .001
No 1,816 (65.5) 797 (67.2) 1,019 (64.2)
Participant does not know 180 (6.4) 135 (11.4) 45 (2.8)
NOTE. Data are No. (%) unless otherwise indicated.
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the same study,20 23.0% checked their breast at 
least once a month compared with only 14.7% 
in this study. The congruent decrease of BSE 
performance and confidence in the ability to 
detect breast changes in this study could be 
explained by the fact that BSE increases body 
awareness, so there is heightened awareness 
of changes that may be detected if BSE is per-
formed regularly.21 Reasons for the poor perfor-
mance in BSE among Palestinian adolescents 
and women might be poor body awareness and 
lack of self-confidence to detect changes as well 
as the belief that a health care professional is 
needed for recognition of abnormalities. BSE is 
rarely talked about in the Gazan public, and find-
ings of this study demonstrate the urgent need 
for public education of adolescents and women 
of all ages about BSE.
In contrast to this study, other studies showed 
better knowledge of age-related BC risk.20,22 This 
might reflect poor health education about the 
age-related risks of BC in the Gaza Strip. Simi-
lar to participants of studies conducted in India 
and Malaysia, participants in this study were 
able to recognize BC symptoms when asked 
closed questions.23,24 However, only a minority 
demonstrated accurate knowledge when asked 
open-ended (recall) questions, which reflects 
the greater difficulty of recall questions. In con-
cordance with other studies from Kuwait and 
Jordan, breast lump or thickening was reported 
as the most frequently recognized BC symptom 
among women in this study.25,26 This result con-
firms the common belief that a breast lump is 
the most concerning BC symptom, from the par-
ticipants’ perspectives, for which they will seek 
medical advice when recognized.
Interestingly, women in Gaza were more aware 
about the BC risk factors than those in the United 
States.27 It is thought that the social interactions 
and life in extended families, which are com-
mon in Gaza, may play roles in this discrepancy, 
because people can talk more with one another 
in person and share information from personal 
and family stories about BC. Another explanation 
could be the increased fear that participants in 
this study reported, which prevented them from 
presenting early to a doctor but also caused a 
heightened awareness of risk factors.
Older women had greater BC awareness than 
adolescents in the Gaza Strip. This was also 
observed in other studies in Qatar,12 Malaysia,23 
and Bangladesh.28 A possible reason for this is 
that such issues are not part of the regular 
school curriculum; also, adolescent girls might 
not be interested in this issue. Adults, con-
versely, already had the opportunity to acquire 
knowledge from encountering similar problems 
over time or from reading and hearing from their 
friends or relatives. In addition, female adoles-
cents possibly feel shy about reading or talking 
about BC or symptoms they might experience, 
which is in concordance with embarrassment as 
the most frequent barrier for presentation to a 
doctor in this study.
Awareness of the availability of a BC screening 
program in Gaza (60.4%) is slightly lower than 
that in Bangladesh (67.0%).28 Surprisingly, 
though, it is still higher than the awareness 
observed in East London, despite the fact that 
the UK breast screening program is highly orga-
nized and invites eligible patients via letter or 
doctors.20 Conversely, Gaza women rely entirely 
on their own motivation, initiative, and knowl-
edge of the program to benefit from it. Therefore, 
a higher awareness would have been expected 
among women in East London. These unex-
pected findings might be caused by the high 
proportion of women in East London who come 
from an immigrant community and who may 
have poor language skills or poor knowledge of 
the local health system.
Forbes et al20 surveyed 1,515 participants in 
East London and reported a mixture of emo-
tional and practical barriers most commonly 
encountered: 47.0% were worried about what 
the doctor might find, 38.0% were embarrassed 
to see the doctor, 37.0% were worried about 
wasting the doctor’s time, and 35.0% found it 
difficult to make an appointment. This is consis-
tent with another study, in which practical bar-
riers were most frequently reported.29 However, 
in this study, emotional barriers were the most 
commonly reported, and higher percentages in 
all emotional barriers versus physical or practi-
cal ones were obtained for each one. The poorer 
knowledge and awareness among Gaza women 
about BC, or local experiences with poor out-
comes because of more advanced-stage presen-
tation, may explain this variation. These reasons 
might drive emotional barriers (such as fear of 
diagnosis) higher in Gaza compared with other 
places.20 Another explanation could be that 
barriers for seeking medical help may depend 
10  jgo.org JGO – Journal of Global Oncology
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on the presenting symptom. A previous study 
showed that women who experienced a breast 
lump were less likely to have a delayed presenta-
tion than those with other symptoms, like nipple 
discharge.30 Accordingly, Meechan et al31 found 
that although women with breast lumps waited 
a shorter time before seeking help, there was 
no difference in the level of emotional response 
to symptoms in the breast lump and non– 
breast-lump groups, which suggests that these 
factors may be operating independently. In con-
trast, breast lump was the most commonly 
reported BC symptom in this study, but most of 
the participants still reported emotional barriers 
that could potentially delay presentation. This 
is in concordance with data from Gaza, which 
showed that women with breast cancer are often 
diagnosed at more advanced disease stages 
because of delayed presentation.32 Another factor 
that may contribute to this delay is the embar-
rassment reported as a barrier to seeing a doctor 
by both adolescents and adults; embarrassment 
might be greater when faced with less well- 
recognized symptoms, such as nipple discharge. 
This factor might be potentiated by the lack 
of female surgeons in Gaza. The first female 
trainee only entered the surgical training in Gaza 
in 2016. Availability of female breast surgeons 
might reduce the embarrassment factor that 
leads to the delay in presentation.
The main strength of this study is the large sam-
ple that gives a representative view of the target 
population. Furthermore, the inclusion of women 
from different age groups and the high response 
rate show general acceptance of such a survey 
by the target population.
Limitations of this study include the lack of socio-
economic data and level of education, which can 
influence knowledge and awareness of BC, as 
well as the lack of additional exploration about 
how much influence factors, such as family history 
of BC and familiarity with the disease through 
friends and neighbors, had on the participants’ 
knowledge and awareness of BC.
The recruitment of women in hospitals might 
have led to the selection of participants who 
were more aware of health issues. Furthermore, 
the inclusion of visitors and the exclusion of 
oncology departments for recruitment reduced 
the number of participants with special aware-
ness of BC because of illness of self or a close 
relative. An additional limitation was the lack of 
closer examination of the barriers to visiting a 
doctor earlier, because that question required a 
different study design.
Early BC detection and disease downstag-
ing remain the cornerstones of BC control to 
improve its outcome and survival in low-income 
countries.33 This study provides evidence that 
the knowledge about BSE practice, symptoms 
and risk factors of BC, and availability of BC 
screening are low, which contributes to the 
advanced presentation and, hence, poor survival 
of patients with BC in the Gaza Strip. Educational 
interventions to raise public awareness of BC and 
to address the emotional barriers to presentation 
to a doctor, such as fear and embarrassment, 
are needed to encourage early presentation and 
improve outcomes.29 More female breast sur-
geons also must be available for consultation 
in the Gaza Strip to facilitate early presentation, 
especially of younger women.
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